From this study, it was revealed that the treatment of EGCG on colorectal cancer cell lines, HT-29, had induced the expressions of UPR-related proteins which are BiP, PERK and its downstream targets (p-eIF2α and ATF4), and IRE1α (Figure 4). The gene discussed is ATF4; the disease is colorectal cancer.